CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 7.09
-0.15 (-2.07%)
Jun 8, 2026, 4:09 PM HKT
CSPC Pharmaceutical Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 82,775 | 96,380 | 55,169 | 86,022 | 97,707 | 100,932 | |
Market Cap Growth | 26.84% | 74.70% | -35.87% | -11.96% | -3.19% | 6.47% |
Enterprise Value | 73,273 | 88,081 | 45,415 | 74,600 | 84,557 | 88,212 |
Last Close Price | 7.24 | 8.43 | 4.65 | 6.73 | 7.30 | 7.35 |
PE Ratio | 22.27 | 22.31 | 11.98 | 13.30 | 14.19 | 14.67 |
Forward PE | 10.71 | 17.08 | 9.76 | 12.05 | 13.86 | 15.70 |
PS Ratio | 2.86 | 3.33 | 1.79 | 2.48 | 2.79 | 2.95 |
PB Ratio | 2.11 | 2.51 | 1.53 | 2.23 | 2.73 | 3.07 |
P/TBV Ratio | 2.40 | 2.86 | 1.76 | 2.53 | 3.08 | 3.24 |
P/FCF Ratio | - | 22.37 | 20.58 | 30.56 | 15.99 | 25.49 |
P/OCF Ratio | - | 14.85 | 11.43 | 18.68 | 11.33 | 17.73 |
PEG Ratio | 1.58 | 1.96 | 1.10 | 1.30 | 1.25 | 1.25 |
EV/Sales Ratio | 2.53 | 3.04 | 1.47 | 2.15 | 2.42 | 2.58 |
EV/EBITDA Ratio | 13.76 | 15.49 | 6.62 | 8.53 | 9.83 | 10.31 |
EV/EBIT Ratio | 19.26 | 19.98 | 7.95 | 9.65 | 11.07 | 11.50 |
EV/FCF Ratio | - | 20.44 | 16.94 | 26.50 | 13.83 | 22.27 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 |
Debt / EBITDA Ratio | 0.13 | 0.12 | 0.08 | 0.09 | 0.08 | 0.01 |
Debt / FCF Ratio | - | 0.17 | 0.20 | 0.28 | 0.11 | 0.03 |
Net Debt / Equity Ratio | -0.28 | -0.28 | -0.25 | -0.37 | -0.44 | -0.42 |
Net Debt / EBITDA Ratio | -2.12 | -1.90 | -1.34 | -1.65 | -1.84 | -1.61 |
Net Debt / FCF Ratio | - | -2.51 | -3.42 | -5.11 | -2.59 | -3.47 |
Asset Turnover | - | 0.57 | 0.64 | 0.71 | 0.81 | 0.86 |
Inventory Turnover | - | 2.88 | 2.78 | 3.26 | 3.45 | 3.10 |
Quick Ratio | - | 1.88 | 1.95 | 2.32 | 2.39 | 2.47 |
Current Ratio | - | 2.19 | 2.27 | 2.63 | 2.67 | 2.81 |
Return on Equity (ROE) | 9.56% | 11.33% | 12.60% | 18.22% | 21.32% | 22.79% |
Return on Assets (ROA) | - | 5.44% | 7.40% | 9.96% | 11.04% | 12.05% |
Return on Invested Capital (ROIC) | 10.88% | 12.76% | 17.69% | 29.11% | 33.40% | 34.94% |
Return on Capital Employed (ROCE) | - | 10.80% | 15.40% | 19.40% | 20.60% | 22.70% |
Earnings Yield | 4.48% | 4.48% | 8.35% | 7.52% | 7.05% | 6.82% |
FCF Yield | - | 4.47% | 4.86% | 3.27% | 6.26% | 3.92% |
Dividend Yield | 4.01% | 3.44% | 5.45% | 4.22% | 2.96% | 2.54% |
Payout Ratio | 43.07% | 64.33% | 74.72% | 46.42% | 34.42% | 30.16% |
Buyback Yield / Dilution | 1.93% | 2.68% | 1.14% | 0.38% | 0.29% | 0.01% |
Total Shareholder Return | 5.94% | 6.12% | 6.59% | 4.60% | 3.25% | 2.55% |